
CSL Ltd
ASX:CSL

CSL Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
248.49
312.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does CSL Ltd hold over its rivals?
What risks and challenges
does CSL Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of CSL Ltd.
Provide an overview of the primary business activities
of CSL Ltd.
What unique competitive advantages
does CSL Ltd hold over its rivals?
What risks and challenges
does CSL Ltd face in the near future?
Has there been any significant insider trading activity
in CSL Ltd recently?
Summarize the latest earnings call
of CSL Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for CSL Ltd.
Provide P/S
for CSL Ltd.
Provide P/E
for CSL Ltd.
Provide P/OCF
for CSL Ltd.
Provide P/FCFE
for CSL Ltd.
Provide P/B
for CSL Ltd.
Provide EV/S
for CSL Ltd.
Provide EV/GP
for CSL Ltd.
Provide EV/EBITDA
for CSL Ltd.
Provide EV/EBIT
for CSL Ltd.
Provide EV/OCF
for CSL Ltd.
Provide EV/FCFF
for CSL Ltd.
Provide EV/IC
for CSL Ltd.
Show me price targets
for CSL Ltd made by professional analysts.
What are the Revenue projections
for CSL Ltd?
How accurate were the past Revenue estimates
for CSL Ltd?
What are the Net Income projections
for CSL Ltd?
How accurate were the past Net Income estimates
for CSL Ltd?
What are the EPS projections
for CSL Ltd?
How accurate were the past EPS estimates
for CSL Ltd?
What are the EBIT projections
for CSL Ltd?
How accurate were the past EBIT estimates
for CSL Ltd?
Compare the revenue forecasts
for CSL Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of CSL Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of CSL Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of CSL Ltd compared to its peers.
Compare the P/E ratios
of CSL Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing CSL Ltd with its peers.
Analyze the financial leverage
of CSL Ltd compared to its main competitors.
Show all profitability ratios
for CSL Ltd.
Provide ROE
for CSL Ltd.
Provide ROA
for CSL Ltd.
Provide ROIC
for CSL Ltd.
Provide ROCE
for CSL Ltd.
Provide Gross Margin
for CSL Ltd.
Provide Operating Margin
for CSL Ltd.
Provide Net Margin
for CSL Ltd.
Provide FCF Margin
for CSL Ltd.
Show all solvency ratios
for CSL Ltd.
Provide D/E Ratio
for CSL Ltd.
Provide D/A Ratio
for CSL Ltd.
Provide Interest Coverage Ratio
for CSL Ltd.
Provide Altman Z-Score Ratio
for CSL Ltd.
Provide Quick Ratio
for CSL Ltd.
Provide Current Ratio
for CSL Ltd.
Provide Cash Ratio
for CSL Ltd.
What is the historical Revenue growth
over the last 5 years for CSL Ltd?
What is the historical Net Income growth
over the last 5 years for CSL Ltd?
What is the current Free Cash Flow
of CSL Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for CSL Ltd.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
AU |
![]() |
CSL Ltd
ASX:CSL
|
121.1B AUD | 5 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 36 551 680.7 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
373.8B USD | 6.6 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
168.4B USD | 5 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
138.9B USD | 4.8 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.7B USD | 11.8 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 1 927.4 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.1B USD | 5.1 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 18.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
32.9B EUR | 16.3 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
31.3B USD | 13.9 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
AU |
![]() |
CSL Ltd
ASX:CSL
|
Average P/S:
3 323 063.2
5
|
7%
|
0.7 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
36 551 680.7
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.6
|
8%
|
0.8 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
5
|
4%
|
1.3 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.8
|
3%
|
1.6 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
11.8
|
10%
|
1.2 |
|
US |
E
|
Epizyme Inc
F:EPE
|
1 927.4
|
N/A | N/A |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
5.1
|
7%
|
0.7 |
|
US |
S
|
Seagen Inc
F:SGT
|
18.6
|
30%
|
0.6 |
|
NL |
![]() |
argenx SE
XBRU:ARGX
|
16.3
|
37%
|
0.4 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
13.9
|
28%
|
0.5 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.